{"disease":{"id":"infection-due-to-resistant-organism","name":"infection due to resistant organism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02922816","title":"FMT for MDRO Colonization After Infection in Renal Transplant Recipients","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT01659515","title":"Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"U.S. Army Medical Research and Development Command","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}